Validation of 46-gene CCP RNA Signature for Predicting PCa Death

Validation of a 46-gene Cell Cycle Progression (CCP) RNA Signature for Predicting Prostate Cancer Death

Peter T. Scardino, MD, FACS
Memorial Sloan Kettering Cancer Center

Click HERE to read an exclusive report by a UroToday medical writer.

Click HERE to view the poster from this session.